ÂÜÀòÂÒÂ×

Hilary Eaton, PhD, is a Chief Business Officer at Profluent and a Scientific Advisory Board Member for the CSNK2A1 Foundation. They previously served as SVP and Head of Business Development at Tome Biosciences and held several key positions in business development at Editas Medicine and Vor Biopharma, where they were a member of the leadership teams. Hilary's career includes a role in technology licensing at the Belfer Office for Dana-Farber Innovations and research as a postdoctoral fellow at Harvard Medical School. They hold a degree from Harvard Medical School.